U.S. markets open in 43 minutes
  • S&P Futures

    +2.00 (+0.05%)
  • Dow Futures

    -16.00 (-0.05%)
  • Nasdaq Futures

    +4.50 (+0.04%)
  • Russell 2000 Futures

    +3.40 (+0.20%)
  • Crude Oil

    -0.76 (-0.94%)
  • Gold

    +6.90 (+0.41%)
  • Silver

    +0.21 (+1.11%)

    -0.0053 (-0.54%)
  • 10-Yr Bond

    -0.0270 (-0.72%)
  • Vix

    +1.53 (+5.07%)

    -0.0045 (-0.41%)

    +0.0370 (+0.03%)

    +80.25 (+0.42%)
  • CMC Crypto 200

    -4.09 (-0.92%)
  • FTSE 100

    -5.52 (-0.08%)
  • Nikkei 225

    -484.84 (-1.83%)

Cano Health's (NYSE:CANO) Returns On Capital Not Reflecting Well On The Business

·3 min read

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increasing base of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Having said that, from a first glance at Cano Health (NYSE:CANO) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look.

What is Return On Capital Employed (ROCE)?

Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. Analysts use this formula to calculate it for Cano Health:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

0.0047 = US$9.4m ÷ (US$2.1b - US$140m) (Based on the trailing twelve months to September 2021).

So, Cano Health has an ROCE of 0.5%. Ultimately, that's a low return and it under-performs the Healthcare industry average of 11%.

Check out our latest analysis for Cano Health


Above you can see how the current ROCE for Cano Health compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Cano Health.

The Trend Of ROCE

On the surface, the trend of ROCE at Cano Health doesn't inspire confidence. Around two years ago the returns on capital were 6.0%, but since then they've fallen to 0.5%. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run.

On a related note, Cano Health has decreased its current liabilities to 6.5% of total assets. That could partly explain why the ROCE has dropped. Effectively this means their suppliers or short-term creditors are funding less of the business, which reduces some elements of risk. Some would claim this reduces the business' efficiency at generating ROCE since it is now funding more of the operations with its own money.

Our Take On Cano Health's ROCE

While returns have fallen for Cano Health in recent times, we're encouraged to see that sales are growing and that the business is reinvesting in its operations. However, despite the promising trends, the stock has fallen 57% over the last year, so there might be an opportunity here for astute investors. As a result, we'd recommend researching this stock further to uncover what other fundamentals of the business can show us.

On a separate note, we've found 2 warning signs for Cano Health you'll probably want to know about.

While Cano Health isn't earning the highest return, check out this free list of companies that are earning high returns on equity with solid balance sheets.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.